Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells

Inflammatory Bowel Diseases

Volumn 13, Issue 10, 2007, Pages 1202-1211

  Stepankova, Renata ^a   Powrie, Fiona ^b   Kofronova, Olga ^a   Kozakova, Hana ^a   Hudcovic, Tomas ^a   Hrncir, Tomas ^a   Uhlig, Holm ^b   Read, Simon ^b   Rehakova, Zuzana ^a   Benada, Oldrich ^a   Heczko, Pioter ^c   Strus, Magda ^c   Bland, Paul ^d,e   Tlaskalova Hogenova, Helena ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Animal model; Colitis; Germ free; Inflammatory bowel disease; Microflora; Regulatory T cells; SFB

Indexed keywords

CD45RB ANTIGEN; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM; BACTEROIDES; CD4+ T LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; ENTERITIS; ENTEROCOCCUS FAECALIS; FUSOBACTERIA; ILEUM; IMMUNOHISTOLOGY; LYMPHOCYTE SUBPOPULATION; MAGNETIC SEPARATION; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HYPERPLASIA; HYPERTROPHY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; SPLEEN;

EID: 35348945960     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20221     Document Type: Article

References (41)

1. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;30:527-530.
2. Powrie F, Leach MW, Mauze S, et al. Phenotypically distinct subsets of CD4+ T cell induce or protect from chronic intestinal inflammation in C.B-17 SCID mice. Int Immunol. 1993;5:1461-1471.
3. Leach MW, Bean GD, Mauye S, et al. Inflammatory bowel disease in CB-17 SCID mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol. 1996;148:1503-1515.
4. Sing B, Read S, Asseman CH, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001;182:190-200.
5. Read S, Malmström V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295-302.
6. Sher A, Kullberg M. Effector and regulatory CD4+ Tcell function in a murine model of Helicobacter hepaticus-induced colitis. J Pediatr Gastroenterol Nutr. 2005;40:S35-36.
7. Asseman C, Read S, Powrie F. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice control by CD4+ regulatory T cells and IL-10. J Immunol. 2003;171:971-978.
8. Foussat A, Cottrez F, Brun V, et al. A comparative study between T regulatory type 1 and CD4+CD25+T cells in the control of inflammation. J Immunol. 2003;171:5018-5026.
9. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004;93:97-108
10. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160:2253-2257.
11. Jiang HQ, Kushnir N, Thurnheer MC, et al. Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology. 2002;122:1346-1354.
12. Stepankova R, Sinkora J, Hudcovic T, et al. Differences in development of lymphocyte subpopulations from gut associated lymphatic tissue (GALT) of germfree and conventional rats: effect of aging. Folia Microbiol. 1998;43:531-534.
13. Fazzi P, Ciancaglini E, Soforza G. Differential fluorescent staining method for detection of bacteria in blood cultures, cerebrospinal fluid and other clinical speciments. Eur J Clin Microbiol Infect Dis. 2002;21:373-378.
14. Fox JG, Gorelick PL, Kullberg MC, et al. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect Immun. 1999;67:1757-1762.
15. Mantz W, Amann R, Ludwig W, et al. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophago-flavobacter-bacteroides in the natural environment. Microbiology. 1996;142:1097-1106.
16. Snel J, Heinen PP, Blok HJ, et al. Comparison of 16rRNA sequences of segmented filamentous bacteria isolated from mice, rats, and chickens and proposal of Candidatus arthromitus. Int J Syst Bacteriol. 1995;45:780-782.
17. Saltzman NH, deJong H, Paterson Y, et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology. 2002;148:3651-3660.
18. Asseman CH, Mauze D, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995-1004.
19. Geboes K, Riddell R, Öst A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404-409.
20. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta 2 microglobulin transgenic rats. J Clin Invest. 1999;98:945-953.
21. van de Merwe JP, Schroder AM, Wensinck F, et al. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand J Gastroenterol. 1988;23:1125-1131.
22. Holdeman LV, Good IJ, Moore WER. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol. 1976;31:359-375.
23. Seksik P, Rigottier-Gois L, Gramet G et al. Alteration of the dominant faecal bacterial groups in patients with Crohn's disease in the colon. Gut. 2003;52:237-242.
24. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.
25. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041.
26. Savage JC. Morphological diversity among members of the gastrointestinal microflora. Int Rev Cytol. 1983;82:305-334.
27. Madsen KL, Doyle JSG, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin-10 gene deficient mice. Gastroenterology. 1997;116:1107-1114.
28. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108-114.
29. Jiang HQ, Bos NA, Cebra JJ. Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups. Infect Immun. 2001;69:3611-3617.
30. Umesaki Y, Setoyama H, Matsumoto S, et al. Differential roles of segmented filamentous bacteria and Clostridia in development of the intestinal immune system. Infect Immun. 1999;67:3504-3511.
31. Yamauchi K, Snel J. Transmission electron microscopic demonstration of phagocytosis and intracellular processing of segmented filamentous bacteria by intestinal epithelial cells of the chick ileum. Infect Immun. 2000;68:6496-6504.
32. Snel J, Blok HJ, Kengen HMP, et al. Phylogenetic characterization of Clostridium related segmented filamentous bacteria in mice based on 16S ribosomal RNA analysis. Syst Appl Microbiol. 1994;17:172-179.
33. Keilbaugh SA, Shin ME, Banchereau RF, et al. Activation of RegIIIβ/γ and interferon γ expression in the intestinal tract of SCID mice: an innate response to bacterial colonization of the gut. Gut. 2005;54:623-629.
34. Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007;56:61-72.
35. Sydora BC, Martin SM, Lupicki M, Dieleman LA, et al. Bacterial antigens alone can influence intestinal barrier integrity, but live bacteria are required for initiation of intestinal inflammation and injury. Inflamm Bowel Dis. 2006;12:429-436.
36. Youakim A, Ahdieh M. Interferon γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Gastroenterol Liver Physiol. 1999;276:1279-1288.
37. Powrie F, Carlino J, Leach MW, et al. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J Exp Med. 1996;183:2669-2674.
38. Walsh SV, Hopkins AM, Nusrat A. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev. 2000;41:303-313.
39. Shao L, Serrano D, Mayer L. The role of epithelial cells in immune regulation in the gut. Immunology. 2001;13:163-173.
40. Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J Clin Invest. 2003;112:648-651.
41. Stepankova R, Kofronova O, Tuckova L, et al. Experimentally induced gluten enteropathy and protective effect of epidermal growth factor in artificially fed neonatal rats. J Pediatr Gastroenterol Nutr. 2003;36:96-104.